To the Editor: Menzies’ recent editorial1 highlights the clear benefits of dermoscopy in the assessment of pigmented lesions. This is well appreciated by anyone who uses this inexpensive handheld tool on a day-to-day basis (its retail price ranges from A$380 to A$1840). Although the potential value of the device has been documented in both specialist and general practice settings, it would seem that most Australian general practitioners aren’t using this valuable technology.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Victorian Melanoma Service, Alfred Hospital, Melbourne, VIC.
- 1. Menzies SW. Technologies for the diagnosis of primary melanoma of the skin [editorial]. Med J Aust 2006; 185: 533-534. <MJA full text>
- 2. Benvenuto-Andrade C, Dusza SW, Agero AL, et al. Differences between polarized light dermoscopy and immersion contact dermoscopy for the evaluation of skin lesions. Arch Dermatol 2007; 143: 329-338.
- 3. Charles CA, Yee VS, Dusza SW, et al. Variation in the diagnosis, treatment and management of melanoma in situ: a survey of US dermatologists. Arch Dermatol 2005; 141: 723-729.